Adjusts Price Target to $30 From $27.50
https://www.marketscreener.com/quote/stock/SERES-THERAPEUTICS-INC-22619573/news/Seres-Therapeutics-nbsp-Chardan-Upgrades-Seres-Therapeutics-to-Buy-From-Neutral-Adjusts-Price-Tar-32615363/
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.